Company: ICUI
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000883984-25-000030
Chunk: 145

Company: ICU MEDICAL INC/DE
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 8
Chunk 145
---
 2024Senior Secured Credit Facilities:Term Loan A — principal7.16 %$559,688 8.03 %$770,313 Term Loan B — principal7.50 %789,500 8.38 %826,625 Revolving Credit Facility — principal— %— — %— Less unamortized debt issuance costs(1)(11,457)(14,080)Total carrying value of long-term debt1,337,731 1,582,858 Less current portion of long-term debt— 51,000 Long-term debt, net$1,337,731 $1,531,858 _______________________________(1)    Comprised of $4.4 million and $7.0 million relating to the Term Loan A and the Term Loan B, respectively, as of June 30, 2025. Comprised of $6.1 million and $8.0 million relating to the Term Loan A and the Term Loan B, respectively, as of December 31, 2024.As of June 30, 2025, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years and thereafter is approximately (in thousands):Remainder of 2025$— 2026— 2027559,688 2028— 2029789,500 2030— Total$1,349,188 

32

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The following table presents the total interest expense related to our long-term debt (in thousands):Three months ended June 30,Six months ended June 30,2025202420252024Contractual interest$23,868 $31,851 $50,756 $64,126 Amortization of debt issuance costs1,783 1,704 3,483 3,411 Commitment fee — Revolving Credit Facility342 379 717 758 Total long-term debt-related interest expense$25,993 $33,934 54,956 68,295 We currently hedge against the contractual interest expense on our long-term debt (see Note 9: Derivatives and Hedging Activities).

Note 19:  Stockholders' Equity